Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients

Journal of Clinical Pathology - Molecular Pathology

Volumn 56, Issue 5, 2003, Pages 263-269

  Dasgupta, S ^a   Chakraborty, S B ^a   Roy, A ^b   Roychowdhury, S ^c   Panda, C K ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b BANKURA SAMMILANI MEDICAL COLLEGE   (India)

^c INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CHROMOSOME 3; CHROMOSOME 3P; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LOCATION; HETEROZYGOSITY; HUMAN; MENOPAUSE; MUTATION; PAPILLOMA VIRUS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; DISEASE PROGRESSION; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0141918874     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.56.5.263     Document Type: Article

References (50)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Sankaranarayanan R, Nair MK, Jayprakash PG, et al. Cervical cancer in Kerala: a hospital registry-based study on survival and prognostic factors. Br J Cancer 1995;72:1039-42.
3. Murthy NS, Mathew A. Screening for cancer of the uterine cervix and approaches adopted in India. Indian J Cancer 1999;36:154-62.
4. Brinton LA, Fraumeni JF, Jr. Epidemiology of uterine cervical cancer. J Chronic Dis 1986;39:1051-65.
5. Ponten J, Adami HO, Bergstrom R, et al. Strategies for global control of cervical cancer. Int J Cancer 1995;60:1-26.
6. Schiffmann MH, Brinton AB. The epidemiology of cervical cancer. Cancer 1995;76:1888-901.
7. Franco EL. Epidemiology in the study of cancer. Encyclopedia of Cancer 1997;1:621-41.
8. Yliotalo N, Sorensen P, Josefesson A, et al. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer 1999;81:365-75.
9. Azzena A, Zen T, Ferrara A, et al. Risk factor for breast cancer. Case-control study results. Eur J Gynaecol Oncol 1994;15:386-92.
10. Tavani A, Negri E, La Vecchia C. Menstrual and reproductive factors and biliary tract cancers. Eur J Cancer Prev 1996;5:241-7.
11. Zur Hausen. Human papilloma virus. Annu Rev Microbiol 1994;48:427-47.
12. Howley PM. Papillomavirinae. The viruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Virology, Vol. 2. Boston: Harvard University, 1995:2045-76.
13. Shah KV, Howley PM. Papilloma viruses. In: Fields BN, Knipe DM, Howley PM, eds. Virology, Vol. 2. Boston: Harvard University, 1995:2077-109.
14. Zur Hausen. Papilloma virus causing cancer: evasion from host cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690-8.
15. Larson AA, Kern S, Sommers RL, et al. Analysis of replication error phenotypes in cervical carcinoma. Cancer Res 1996;56:1426-31.
16. Lazo PA. The molecular genetics of cervical carcinoma. Br J Cancer 1999;80:2008-18.
17. Heselmeyer K, Schrock E, du Manoir S, et al. Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 1996;93:479-84.
18. Allen DG, White DJ, Hutchins AM, et al. Progressive genetic aberrations detected by comparative genomic hybridisation in squamous cell cervical cancer. Br J Cancer 2000;83;1659-63.
19. Mitra AB, Murty V, Li RG, et al. Allelotype analysis of cervical carcinoma. Cancer Res 1994;54:4481-7.
20. Mullokandov MR, Kholodilov NG, Atkin NB, et al. Genomic alteration in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Cancer Res 1996;56:197-205.
21. Larson AA, Kern S, Curtiss S, et al. High resolution analysis of chromosome 3p alterations in cervical cancer. Cancer Res 1997;57:4082-90.
22. Wistuba II, Montellao FD, Milchgrub S, et al. Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 1997;57:3154-8.
23. Guo Z, Hu X, Afink G, et al. Comparisons of chromosome 3p deletions between cervical precancer synchronous with and without invasive cancer. Int J Cancer 2000;86:518-23.
24. Fishel R. Genomic instability, mutators, and the development of cancer: is there a role for p53? J Natl Cancer Inst 1996;88:1608-9.
25. Hampton GM, Larson AA, Baergen RN, et al. Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence-based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci USA 1996;93:6704-9.
26. Dasgupta S, Mukherjee N, Roy S, et al. Mapping of the candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of Indian patient population. Oral Oncol 2002;38:6-15.
27. Melamed J, Einhorn JM, Ittamann MM. Allelic loss on chromosome 13q in human prostate carcinoma. Clin Cancer Res 1997;3:1867-72.
28. Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999;18:643-50.
29. Dillon EK, Boer WB, De Papadimitriou JM, et al. Microsatellite instability and loss of heterozygosity in mammary carcinoma and its probable precursors. Br J Cancer 1997;76:156-62.
30. Ishwad CS, Ferrel RE, Rossie KM, et al. Microsatellite instability in oral cancer. Int J Cancer 1995;64:332-5.
31. D'Costa J, Saranath D, Dedhia P, et al. Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol 1998;34:413-20.
32. Park JS, Dong SM, Kim HS, et al. Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study. Cancer Lett 1999;136:101-8.
33. Balaram P, Nalinakumari KR, Abraham E, et al. Human papilloma viruses in 91 oral cancers from Indian betel quid chewers - high prevalence and multiplicity of infections. Int J Cancer 1995;61:450-4.
34. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papilloma virus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
35. Chung GT, Huang DP, Lo KW, et al. Genetic lesions in the carcinogenesis of cervical cancer. Anticancer Res 1992;12:1485-90.
36. Kok K, Naylor SL, Buys CHCM. Deletion of the short arm of chromosome 3 in solid tumors and the search for tumor suppressor genes. Adv Cancer Res 1997;71:27-92.
37. Papadopoulos N, Necolaids NC, Wei YF, et al. Mutation of a mutL homologue in hereditary colon cancer. Science 1994;263:1625-9.
38. Benachenhou N, Guiral S, Gorska-Flipot I, et al. Frequent loss of heterozygosity at the DNA mismatch repair loci hMLH1 and hMSH3 in sporadic breast cancer. Br J Concer 1909;79:1012-17.
39. Daigo Y, Nishiwaki T, Kawasoe T, et al. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res 1999;59:1966-72.
40. Kersemaekers AM, Hermans J, Fleuren GJ, et al. Loss of heterozygosity for defined regions on chromosome 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer 1998;77:192-200.
41. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers Oncogene 2002;21:6915-35.
42. Aburatani H, Wang Y, Shibata H, et al. Identification of a region of homozygous deletion in cervical carcinoma [abstract]. Am J Hum Genet 1994;55:A51.
43. Wong WF, Chung TK, Cheung TH, et al. Frequent loss of heterozygosity of chromosome 3 short arm detected by PCR based microsatellite polymorphism in cervical squamous cell carcinoma. Cancer Lett 1997;115:161-4.
44. Sundaresan V, Chung G, Heppel-Parton A, et al. Homozygous deletion at 3p12 in breast and lung cancer. Oncogene 1998;17:1723-9.
45. Lovell M, Lott ST, Wong P, et al. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation. Cancer Res 1999;59:2182-9.
46. Chakraborty SB, Dasgupta S, Roy A, et al. Differential deletions in chromosome 3p are associated with the development of head and neck squamous cell carcinoma from Indian patients. Cancer Genet and Cytogenet [In press.]
47. Scholes AGM, Woolger JA, Boyle MA, et al. Synchronous oral carcinomas: independent or common clonal origin? Cancer Res 1998;58:2003-6.
48. Adamson R, Jones AS, Field JK. Loss of heterozygosity studies on chromosome 17 in head and neck cancer using microsatellite markers. Oncogene 1994;9:2077-83.
49. Munger K, Heselmeyer K. The molecular pathogenesis of cervical cancer; the role of human papilloma virus. In: Gazdar A, Srivastava S, Henson DE, et al, eds, Molecular pathology of early cancer. Amsterdam: IOS Press, 1999:97-111.
50. Huebner K. Tumor suppressor on 3p: a neoclassic quartet. Proc Natl Acad Sci USA 2001;98:14763-5.